QA: Abbvie Inc in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001551152_2019_Abbvie_Inc.pdf

Logs

Graph

Absolute values for 0001551152, Abbvie Inc

  xvar xval
0 AssetsCurrent 16,945,000,000
1 IntangibleAssetsNetIncludingGoodwill 36,896,000,000
2 PropertyPlantAndEquipmentNet 2,883,000,000
3 remainder_Assets 2,628,000,000
4 LiabilitiesCurrent 17,239,000,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 7,718,000,000
8 SellingGeneralAndAdministrativeExpense 7,850,749,622
9 ResearchAndDevelopmentExpense 16,485,126,049
10 remainder_Expenses 2,316,251,752
11 remainder_Revenues 33,483,195,757
12 remainder_NetIncome -1,178,708,084
13 remainder_ComprehensiveNetIncome 117,103,639
  yvar yval
0 Assets 59,352,000,000
1 Liabilities 17,239,000,000
2 Expenses 34,370,127,423
3 Revenues 33,483,195,757
4 StockholdersEquity 42,113,000,000
5 NetIncome -2,065,639,750
6 ComprehensiveNetIncome -2,007,087,930
7 BaseVar 72,870,067,452
8 EconomicCapitalRatiobeforeLimitedLiability 2.34
9 EconomicCapitalRatio 3.25

Edgar->Model Mapping

Feature Distribution

Change over Time